Head-to-Head

Arcturus Therapeutics Holdings Inc. Common Stock vs. Johnson & Johnson

ARCT

Arcturus Therapeutics Holdings Inc. Common Stock

$14.46 -4.77%

VS JNJ

Johnson & Johnson

$268.04 +0.85%

Johnson & Johnson (JNJ) comes out ahead, leading on 6 of 8 compared factors.

Size & Scale

ARCTJNJ
Market Cap $431.75 million $645.95 billion
Revenue (TTM) $29.37 million $97.93 billion
Net Income (TTM) $-93,276,000 $21.04 billion

JNJ leads on 3 of 3 size & scale factors.

Valuation

ARCTJNJ
P/E Ratio — 31.10
Price / Book 2.51 7.60
Price / Sales 14.70 6.60

ARCT and JNJ split the valuation factors evenly.

Profitability

ARCTJNJ
Net Margin -317.62% 21.48%
Return on Equity -54.29% 24.76%

JNJ leads on 2 of 2 profitability factors.

Dividend

ARCTJNJ
Dividend Yield — 2.00%
Payout Ratio — 62.18

ARCT and JNJ split the dividend factors evenly.

Risk & Sentiment

ARCTJNJ
Short Interest 0.22% 0.67%

ARCT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ARCT overview, ARCT financials, JNJ overview, JNJ financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.